PMC:7461420 / 93482-93590
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T437 | 97-101 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1045 | 7-16 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signaling |
T1046 | 64-70 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T684 | 17-35 | Chemical | denotes | pathway inhibitors | http://purl.obolibrary.org/obo/CHEBI_76932 |
T685 | 25-35 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T686 | 36-44 | Chemical | denotes | imatinib | http://purl.obolibrary.org/obo/CHEBI_45783 |
T687 | 49-58 | Chemical | denotes | dasatinib | http://purl.obolibrary.org/obo/CHEBI_49375|http://purl.obolibrary.org/obo/CHEBI_70839 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T119 | 7-24 | http://purl.obolibrary.org/obo/GO_0007165 | denotes | signaling pathway |
T120 | 7-16 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signaling |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2856 | 84-92 | Species | denotes | MERS‐CoV | Tax:1335626 |
2857 | 97-105 | Species | denotes | SARS‐CoV | Tax:694009 |
2858 | 36-44 | Chemical | denotes | imatinib | MESH:D000068877 |
2859 | 49-58 | Chemical | denotes | dasatinib | MESH:D000069439 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T830 | 0-108 | Sentence | denotes | Kinase signaling pathway inhibitors imatinib and dasatinib were active against both MERS‐CoV and SARS‐CoV‐1. |